Yuxi Wen

Yuxi Wen

Auto-generated profile, based on publicly available information

Yuxi Wen

College of Marine Sciences, Fujian Agriculture and Forestry University, No. 15 Shangxiadian Road, Fuzhou 350002, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
YWYuxi Wen
Yuxi Wen
LGLuying Gao
Luying Gao
HZHengsheng Zhou
Hengsheng Zhou
CAChao Ai
Chao Ai
XHXiaozhou Huang
Xiaozhou Huang
CZChao Zhao
Chao Zhao


23 July 2023 in Foods
Verified
Journal Article
Open access
PDF file
JLJoux Lee
Joux Lee
XCXiaohua CHEN
Xiaohua CHEN
ZXZiyan Xie
Ziyan Xie
LLLin Liang
Lin Liang
ALAnping Li
Anping Li
ZLZaixiang Lou
Zaixiang Lou
Pseudomonas aeruginosa is a conditional Gram-negative pathogen that produces extracellular virulence factors that can lead to bloodstream invasion, severely harm tissues, and disseminate bacteria, ultimately leading to various diseases. In this study, lactic acid bacteria (LAB) with strong antagonistic ability against P. aeruginosa were screened, and the regulatory mechanism of LAB against P. aeruginosa was evaluated. The results showed that the three selected LAB strains had strong inhibition ability on the growth, biofilm formation, and pyocyanin expression of P. aeruginosa and a promoting effect on the expression of autoinducer-2. Among them, Lactipantibacillus plantarum (Lp. plantarum) LPyang is capable of affecting the metabolic processes of P. aeruginosa by influencing metabolic substances, such as LysoPC, oxidized glutathione, betaine, etc. These results indicate that LPyang reduces the infectivity of P. aeruginosa through inhibition of its growth, biofilm formation, pyocyanin expression, and regulation of its metabolome. This study provides new insights into the antagonistic activity of Lp. plantarum LPyang against P. aeruginosa.

13 July 2022 in Food Frontiers
Verified
Journal Article
Open access
YWYuxi Wen
Yuxi Wen
YLYuanyuan Liu
Yuanyuan Liu
QHQihui Huang
Qihui Huang
Mohamed FaragMohamed Farag
Mohamed Farag
XLXiaoqing Li
Xiaoqing Li
CZChao Zhao
Chao Zhao
Diabetes is a chronic disease, and its complexity and its various complications complicate studies in diabetes management. Aging is one of the main risk factors for diabetes, and elderly are a high‐risk group for developing the disease. In recent years, increasing evidence has revealed the underlying molecular basis for aging diabetes and its connection to related signal pathways. Several key pathways in the aging process can affect insulin secretion and induce diabetes. In this review, we propose a possible connection between diabetes and aging in terms of development timeline and molecular pathology to better understand this interaction between two diseases, especially aging diabetes. Additionally, cell and animal models associated with diabetes are summarized, as well as a summary of models currently being used to study aging diabetes, and their strengths and limitations are also presented. The explanation of these types of models would help us to better understand the relationship between type 2 diabetes and aging and provide a basis for subsequent research on disease mechanisms and/or drug development.

1 November 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YCYihan Chen
Yihan Chen
DLDan Liu
Dan Liu
YWYuxi Wen
Yuxi Wen
CZChao Zhao
Chao Zhao

13 April 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
QLQiuzhe Li
Qiuzhe Li
YLYuanyuan Liu
Yuanyuan Liu
SSShuo Shan
Shuo Shan
YWYuxi Wen
Yuxi Wen
XWXue Wu
Xue Wu
WCWeichao Chen
Weichao Chen
Styela plicata, an edible ascidian rich in diverse bioactive constituents, represents a promising source of marine natural products for therapeutic discovery. Here, bioactive components from a 95% ethanol extract of S. plicata (ESP) were characterized by HPLC-MS/MS, showing that the major constituents were oxygenated small molecules dominated by fatty acyls and carboxylic acid derivatives. In a mouse model of alcohol-induced liver injury, H-ESP treatment (300 mg/kg) significantly reduced serum levels of AST, ALT, and TG (p < 0.01), while effectively ameliorating pathological changes in liver tissue, reducing lipid accumulation and inflammatory responses. Transcriptome sequencing (H-ESP vs. model group) identified 1097 differentially expressed genes (172 upregulated and 925 downregulated), and KEGG analysis highlighted significant enrichment of the Toll-like receptor signaling pathway. ESP modulated hepatic metabolite expression, suppressed inflammation via TLR-4/NF-κB pathway inhibition, and boosted antioxidant defenses by activating Nrf2/HO-1 signaling, which was further confirmed by RT-qPCR and immunohistochemistry. ESP increased intestinal SCFAs (acetate, propionate, isobutyrate; p < 0.05), improved α-diversity and the Firmicutes/Bacteroidetes ratio, reversed shifts in Lactobacillus and Bifidobacterium, and partly restored Odoribacter, supporting a gut–liver axis mechanism. Overall, these findings indicate that ESP exerts hepatoprotective effects by modulating the gut–liver axis, and they provide insights for developing natural therapeutics against alcoholic liver disease.